81 related articles for article (PubMed ID: 15459498)
1. Clinicopathological significance of stromelysin-3 expression in colorectal cancer.
Skoglund J; Emterling A; Arbman G; Anglard P; Sun XF
Oncology; 2004; 67(1):67-72. PubMed ID: 15459498
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of stromelysin-3, BM-40/SPARC, and MET genes in human esophageal carcinoma: implications for prognosis.
Porte H; Triboulet JP; Kotelevets L; Carrat F; Prévot S; Nordlinger B; DiGioia Y; Wurtz A; Comoglio P; Gespach C; Chastre E
Clin Cancer Res; 1998 Jun; 4(6):1375-82. PubMed ID: 9626453
[TBL] [Abstract][Full Text] [Related]
3. Topoisomerase I protein expression in primary colorectal cancer and lymph node metastases.
Boonsong A; Curran S; McKay JA; Cassidy J; Murray GI; McLeod HL
Hum Pathol; 2002 Nov; 33(11):1114-9. PubMed ID: 12454816
[TBL] [Abstract][Full Text] [Related]
4. Lactate dehydrogenase 5 expression in operable colorectal cancer: strong association with survival and activated vascular endothelial growth factor pathway--a report of the Tumour Angiogenesis Research Group.
Koukourakis MI; Giatromanolaki A; Sivridis E; Gatter KC; Harris AL;
J Clin Oncol; 2006 Sep; 24(26):4301-8. PubMed ID: 16896001
[TBL] [Abstract][Full Text] [Related]
5. Metastatic potential in T1 and T2 colorectal cancer.
Fang WL; Chang SC; Lin JK; Wang HS; Yang SH; Jiang JK; Chen WC; Lin TC
Hepatogastroenterology; 2005; 52(66):1688-91. PubMed ID: 16334758
[TBL] [Abstract][Full Text] [Related]
6. [Lymph node micrometastases and expression of metastasis-related gene proteins in patients with colorectal cancer].
Fan YZ; Li XP; Liu WF; Li GM
Zhonghua Wai Ke Za Zhi; 2006 Feb; 44(3):181-5. PubMed ID: 16635348
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of alpha-methylacyl-coenzyme A racemase in colorectal carcinoma bears clinical and pathologic significance.
Lin A; Weiser MR; Klimstra DS; Paty PB; Tang LH; Al-Ahmadie H; Hoo Park S; Guillem JG; Temple L; Wong WD; Gerald WL; Shia J
Hum Pathol; 2007 Jun; 38(6):850-6. PubMed ID: 17442371
[TBL] [Abstract][Full Text] [Related]
8. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
[TBL] [Abstract][Full Text] [Related]
9. Tissue factor expression and metastatic potential of colorectal cancer.
Shigemori C; Wada H; Matsumoto K; Shiku H; Nakamura S; Suzuki H
Thromb Haemost; 1998 Dec; 80(6):894-8. PubMed ID: 9869156
[TBL] [Abstract][Full Text] [Related]
10. Significance of immunohistochemical expression of manganese superoxide dismutase as a marker of malignant potential in colorectal carcinoma.
Nozoe T; Honda M; Inutsuka S; Yasuda M; Korenaga D
Oncol Rep; 2003; 10(1):39-43. PubMed ID: 12469142
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of Smac/DIABLO expression in colorectal cancer.
Endo K; Kohnoe S; Watanabe A; Tashiro H; Sakata H; Morita M; Kakeji Y; Maehara Y
Oncol Rep; 2009 Feb; 21(2):351-5. PubMed ID: 19148507
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of ras is an independent prognostic factor in colorectal adenocarcinoma.
Sun XF; Ekberg H; Zhang H; Carstensen JM; Nordenskjöld B
APMIS; 1998 Jun; 106(6):657-64. PubMed ID: 9725799
[TBL] [Abstract][Full Text] [Related]
13. Expression of stromelysin-3 in medullary carcinoma of the breast.
Holm R; Flørenes VA; Erikstein B; Nesland JM
Anticancer Res; 1997; 17(5B):3725-7. PubMed ID: 9427769
[TBL] [Abstract][Full Text] [Related]
14. Reduced expression of Apaf-1 in colorectal adenocarcinoma correlates with tumor progression and aggressive phenotype.
Paik SS; Jang KS; Song YS; Jang SH; Min KW; Han HX; Na W; Lee KH; Choi D; Jang SJ
Ann Surg Oncol; 2007 Dec; 14(12):3453-9. PubMed ID: 17882496
[TBL] [Abstract][Full Text] [Related]
15. Leptin expression correlates with favorable clinicopathologic phenotype and better prognosis in colorectal adenocarcinoma.
Paik SS; Jang SM; Jang KS; Lee KH; Choi D; Jang SJ
Ann Surg Oncol; 2009 Feb; 16(2):297-303. PubMed ID: 19050975
[TBL] [Abstract][Full Text] [Related]
16. Stromelysin 3: an independent prognostic factor for relapse-free survival in node-positive breast cancer and demonstration of novel breast carcinoma cell expression.
Ahmad A; Hanby A; Dublin E; Poulsom R; Smith P; Barnes D; Rubens R; Anglard P; Hart I
Am J Pathol; 1998 Mar; 152(3):721-8. PubMed ID: 9502414
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of stromelysin-3 and tissue inhibitor of matrix metalloproteinase-2 in esophageal cancer.
Sharma R; Chattopadhyay TK; Mathur M; Ralhan R
Oncology; 2004; 67(3-4):300-9. PubMed ID: 15557792
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of cyclooxygenase-2 correlates with advanced stages of colorectal cancer.
Zhang H; Sun XF
Am J Gastroenterol; 2002 Apr; 97(4):1037-41. PubMed ID: 12003384
[TBL] [Abstract][Full Text] [Related]
19. Expression of p16 in lymph node metastases of adjuvantly treated stage III colorectal cancer patients identifies poor prognostic subgroups: a retrospective analysis of biomarkers in matched primary tumor and lymph node metastases.
Karamitopoulou E; Zlobec I; Koumarianou A; Patsouris ES; Peros G; Lugli A
Cancer; 2010 Oct; 116(19):4474-86. PubMed ID: 20572035
[TBL] [Abstract][Full Text] [Related]
20. Tumor budding is predictive of lymphatic involvement and lymph node metastases in submucosal invasive colorectal adenocarcinomas and in non-polypoid compared with polypoid growths.
Ogawa T; Yoshida T; Tsuruta T; Tokuyama W; Adachi S; Kikuchi M; Mikami T; Saigenji K; Okayasu I
Scand J Gastroenterol; 2009; 44(5):605-14. PubMed ID: 19221929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]